Scienion, Innopsys to Offer Combined Technologies | GenomeWeb

NEW YORK (GenomeWeb News) – Scienion and Innopsys today announced an agreement to combine each other's microarray technologies in a single offering to customers.

The firms said they will integrate their technologies for a broad range of applications and highlighted the integration of Scienion's sciFlexArrayer technology, which can be used for reverse-phase protein arrays, with Innopsys' InnoScan 710-IR near-infrared scanner, resulting in a product that "will significantly improve signal-to-noise ratios."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.